Innervace is a regenerative therapy company developing technology that acts as pre-formed, anatomically-inspired, implantable tissue pathways to directly replace lost connections due to brain degeneration or injury.
Our lead program mimics the lost migrostriatal pathway in patients with Parkinson’s disease (PD).
Company Details
- Founded
- -
- Address
- New York, Ny, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.innervace.com
- HQ
- New York, NY
Innervace Questions
Innervace's website is http://www.innervace.com
Innervace's LinkedIn profile is https://www.linkedin.com/company/innervace
Innervace's industry is
Biotechnology Research
Innervace's top competitors are
Precision Neuroscience,
Neochromosome, Inc.,
Aviko Radiopharmaceuticals,
Storied Ventures,
Accurkardia,
Biotia,
Pavmed Inc.,
Concarlo Therapeutics,
Inso Biosciences,
Evoke Neuroscience.
Innervace's categories are Biotechnology Research
Innervace's founding year is 2020
